Corning Inc · GLW · FY2025 Q2 · Calendar Q3 2025

Corning's AI-fiber momentum supports growth, with tariff and ramp risks

The available call analysis supports a constructive growth case centered on GenAI-driven fiber demand, carrier DCI deployments, and solar capacity expansion. The case is conditional: management must convert demand and customer commitments into shipments while absorbing ramp costs and navigating tariff and macro uncertainty.

Reported Before market openNYSETechnology $140.59B market cap
90quality score

Earnings scorecard

Reported versus consensus
Reported EPS $0.60 Consensus $0.57
EPS surprise +5.1% Reported versus consensus
Reported revenue $3.86B Consensus $3.86B
Revenue surprise +0.2% Reported versus consensus

Market reaction

prior-close to event-session close
Stock move +11.9% Event window
SPY move -0.3% Same window
Abnormal move +12.1% Stock minus SPY
Volume 4.2× Versus trailing sessions
Subsequent drift +8.7% Up to 20 sessions
GLWSPY benchmark

Ask FN2 about GLW FY2025 Q2

Transcript, numbers and history already loaded

Free account. Your question opens in FN2 with this report's transcript and numbers attached.

Transcript intelligence

What changed

No prior-quarter transcript analysis was supplied, so a quarter-over-quarter change assessment is not available. In the available Q2 analysis, management highlighted record sales and EPS, stronger optical demand tied to AI infrastructure, solar capacity commitments, maintained Q3 guidance, and temporary tariff pull-forward and ramp-cost effects.

Guidance delta

Management maintained guidance and expected Q3 sales growth in the double digits, with EPS of $0.63-$0.67; tariff pull-forward effects were included and expected to normalize in the second half.

Key takeaways

  • Management described strong demand for GenAI data-center fiber and carrier DCI products.
  • The call analysis indicated Q2 sales and EPS exceeded expectations while operating margin expanded toward the 20% Springboard target.
  • Management said the solar business is supported by U.S.-based polysilicon and wafer assets and customer commitments.
  • The growth outlook is balanced by temporary ramp costs, tariff normalization, and uncertainty around macro demand.

Management priorities

  • Commercialize new wafer products in Q3 and increase shipments in Q4.
  • Scale high-density fiber and DCI offerings.
  • Advance the U.S. advanced manufacturing footprint through customer negotiations.
  • Invest about $1.3 billion in 2025 capital expenditures while continuing the share repurchase and dividend programs.

Follow GLW with an agent that reads every filing, transcript, and price print. Free to start.

Try FN2 free

Earnings History

Estimate Beat Miss Match
GLW EPS earnings history estimate and actual scatter chart 9 reported fiscal quarters and 4 future estimate-only quarters. Q1 '24 estimate $0.35 Q1 '24 actual $0.38, beat Q2 '24 estimate $0.46 Q2 '24 actual $0.47, match Q3 '24 estimate $0.53 Q3 '24 actual $0.54, beat Q2 '25 estimate $0.57 Q2 '25 actual $0.60, beat Q3 '25 estimate $0.67 Q3 '25 actual $0.67, match Q4 '25 estimate $0.71 Q4 '25 actual $0.72, beat Q1 '26 estimate $0.69 Q1 '26 actual $0.70, match Q2 '26 estimate $0.76 Q2 '26 actual $0.78, beat Q3 '26 estimate $0.88 Q4 '26 estimate $0.93 Q1 '27 estimate $0.90 Q2 '27 estimate $1.02
Show 1 more >

Analyst Consensus ?

ConsensusHold37 ratings
Bullish2156.8%
Neutral1437.8%
Bearish25.4%

Analyst 52W Price Targets

$163.25Previous close
$45Low
$138.09Average
$230High

Latest persisted target per named analyst; persisted previous close from FN2's market snapshot as of Oct 8, 2026. Not an FN2 forecast.

Firm-level rating actions

FMP grade actions identify the grading firm, not a named analyst.

FirmRatingPrior ratingActionDate
UBS Buy BuyMaintainOct 5, 2026
Truist Securities Buy BuyMaintainOct 2, 2026
Mizuho Outperform OutperformMaintainSep 15, 2026
Oppenheimer Outperform OutperformMaintainJul 29, 2026
Morgan Stanley Equal Weight Equal WeightMaintainJul 29, 2026
JP Morgan Neutral NeutralMaintainJul 29, 2026
Citigroup Buy BuyMaintainJul 29, 2026
Barclays Equal Weight Equal WeightMaintainJul 29, 2026
B of A Securities Buy BuyMaintainJul 6, 2026
Susquehanna Positive PositiveMaintainApr 29, 2026
Argus Research Buy BuyMaintainOct 29, 2025
HSBC Buy HoldUpgradeJan 30, 2025
Deutsche Bank Buy BuyMaintainOct 30, 2024
Fox Advisors Overweight Equal WeightUpgradeJun 17, 2024
Credit Suisse Outperform OutperformMaintainJul 26, 2023
Goldman Sachs Buy NeutralUpgradeJan 27, 2022
Cross Research Neutral BuyDowngradeSep 17, 2019
Bank of America Buy NeutralUpgradeMay 1, 2019
Bernstein Market Perform OutperformDowngradeFeb 1, 2017
Guggenheim Buy BuyMaintainJan 4, 2017
Wells Fargo Perform Market PerformMaintainDec 21, 2016
Standpoint Research Hold BuyDowngradeJun 13, 2016
Drexel Hamilton Sell BuyDowngradeJun 10, 2016
Sterne Agee CRT Neutral NeutralMaintainSep 28, 2015
Benchmark Hold HoldMaintainJul 29, 2015
RBC Capital Outperform Sector PerformUpgradeJun 16, 2015
CLSA Sell UnderperformMaintainApr 29, 2015
Jefferies Hold HoldMaintainFeb 2, 2015
Standpoint Buy HoldUpgradeOct 15, 2014
Stifel Nicolaus Buy BuyMaintainOct 23, 2013
Stifel Buy BuyMaintainOct 23, 2013
Sterne Agee Neutral BuyDowngradeOct 23, 2013
PiperJaffray Neutral OverweightDowngradeOct 11, 2013
Piper Sandler Neutral OverweightDowngradeOct 11, 2013
Gilford Securities Buy BuyMaintainSep 23, 2013
Cantor Fitzgerald Hold HoldMaintainSep 19, 2013
Topeka Buy BuyMaintainNov 27, 2012
Show less

Named analyst price targets

Upside is calculated against the persisted previous close $163.25. FMP does not supply a rating on these named-analyst rows.

FirmAnalyst52W targetPrice when postedUpsideDate
UBSAnalyst unavailable$201$164.16 +23.1%Oct 5, 2026
BernsteinDaniel Zhu$140$158.75 -14.2%Sep 30, 2026
Mizuho SecuritiesJohn Roberts$180$143.5 +10.3%Sep 15, 2026
Truist FinancialAnalyst unavailable$175$138.25 +7.2%Aug 2, 2026
Morgan StanleyAnalyst unavailable$165$125.88 +1.1%Jul 29, 2026
Mizuho SecuritiesAnalyst unavailable$210$125.88 +28.6%Jul 29, 2026
UBSJoshua Spector$196$125.88 +20.1%Jul 29, 2026
OppenheimerAnalyst unavailable$200$125.88 +22.5%Jul 29, 2026
BarclaysTim Long$129$125.88 -21.0%Jul 29, 2026
OppenheimerMartin Yang$230$194.77 +40.9%Jul 7, 2026
UBSAnalyst unavailable$243$196.7 +48.9%Jul 6, 2026
Mizuho SecuritiesJohn Roberts$270$255.54 +65.4%Jul 1, 2026
Truist FinancialMatthew Niknam$205$195 +25.6%Jun 22, 2026
UBSJoshua Spector$228$197.93 +39.7%Jun 5, 2026
Mizuho SecuritiesAnalyst unavailable$220$207.3 +34.8%May 12, 2026
Morgan StanleyMeta Marshall$180$192.7 +10.3%May 8, 2026
BarclaysTim Long$180$182.42 +10.3%May 8, 2026
UBSAnalyst unavailable$223$181.57 +36.6%May 7, 2026
Truist FinancialAnalyst unavailable$149$149.3 -8.7%Apr 29, 2026
SusquehannaAnalyst unavailable$180$153.05 +10.3%Apr 29, 2026
BarclaysTim Long$149$153.05 -8.7%Apr 29, 2026
Morgan StanleyMeta Marshall$140$164.37 -14.2%Apr 20, 2026
Mizuho SecuritiesAnalyst unavailable$160$165.1 -2.0%Apr 8, 2026
Morgan StanleyAnalyst unavailable$127$139.51 -22.2%Feb 23, 2026
Mizuho SecuritiesAnalyst unavailable$145$139.51 -11.2%Feb 23, 2026
HSBCStephen Bersey$135$131.5 -17.3%Feb 13, 2026
UBSJoshua Spector$125$105.58 -23.4%Jan 30, 2026
Morgan StanleyAnalyst unavailable$103$100.86 -36.9%Jan 29, 2026
OppenheimerAnalyst unavailable$120$102.76 -26.5%Jan 29, 2026
SusquehannaAnalyst unavailable$125$104.29 -23.4%Jan 29, 2026
Mizuho SecuritiesAnalyst unavailable$120$104.29 -26.5%Jan 29, 2026
BarclaysAnalyst unavailable$100$104.29 -38.7%Jan 29, 2026
Wolfe ResearchGeorge Notter$130$110.98 -20.4%Jan 27, 2026
Morgan StanleyMeta Marshall$98$86.29 -40.0%Dec 17, 2025
UBSAnalyst unavailable$109$78.03 -33.2%Nov 21, 2025
Argus ResearchAnalyst unavailable$110$91.56 -32.6%Oct 29, 2025
UBSAnalyst unavailable$100$87.5 -38.7%Oct 29, 2025
Morgan StanleyAnalyst unavailable$82$87.5 -49.8%Oct 29, 2025
Mizuho SecuritiesAnalyst unavailable$97$86.43 -40.6%Oct 29, 2025
OppenheimerAnalyst unavailable$100$87.5 -38.7%Oct 29, 2025
SusquehannaAnalyst unavailable$100$90.01 -38.7%Oct 29, 2025
BarclaysAnalyst unavailable$83$86.43 -49.2%Oct 29, 2025
Morgan StanleyAnalyst unavailable$75$87.19 -54.1%Oct 10, 2025
Mizuho SecuritiesAnalyst unavailable$90$82.52 -44.9%Oct 3, 2025
UBSJoshua Spector$91$79.16 -44.3%Sep 23, 2025
UBSAnalyst unavailable$84$68.47 -48.5%Sep 2, 2025
Mizuho SecuritiesJohn Roberts$74$65.77 -54.7%Aug 8, 2025
Morgan StanleyAnalyst unavailable$56$62.61 -65.7%Jul 30, 2025
OppenheimerAnalyst unavailable$72$62.61 -55.9%Jul 30, 2025
SusquehannaAnalyst unavailable$75$62.61 -54.1%Jul 30, 2025
Mizuho SecuritiesJohn Roberts$59$53.04 -63.9%Jul 15, 2025
Mizuho SecuritiesJohn Roberts$52$42 -68.1%Apr 15, 2025
HSBCStephen Bersey$60$49.8 -63.2%Jan 30, 2025
OppenheimerMartin Yang$58$48.84 -64.5%Oct 30, 2024
Deutsche BankMatt Niknam$54$49.03 -66.9%Oct 30, 2024
BarclaysTim Long$53$49.03 -67.5%Oct 29, 2024
Bank of America SecuritiesWamsi Mohan$56$49.03 -65.7%Oct 29, 2024
Deutsche BankMatt Niknam$49$45.66 -70.0%Oct 9, 2024
Mizuho SecuritiesJohn Roberts$51$44.65 -68.8%Sep 24, 2024
Bank of America SecuritiesWamsi Mohan$51$44.3 -68.8%Sep 20, 2024
SusquehannaMehdi Hosseini$55$44.33 -66.3%Sep 20, 2024
OppenheimerMartin Yang$51$44.43 -68.8%Sep 20, 2024
CitigroupAsiya Merchant$50$41.37 -69.4%Sep 6, 2024
Mizuho SecuritiesJohn Roberts$47$40.73 -71.2%Aug 21, 2024
Bank of America SecuritiesWamsi Mohan$46$39.74 -71.8%Jul 31, 2024
Deutsche BankMatt Niknam$46$39.74 -71.8%Jul 31, 2024
Morgan StanleyMeta Marshall$39$42.9 -76.1%Jul 26, 2024
Argus ResearchJim Kelleher$50$43.05 -69.4%Jul 9, 2024
Mizuho SecuritiesJohn Roberts$42$38.75 -74.3%Jun 18, 2024
US Capital AdvisorsSteve Fox$45$37.25 -72.4%Jun 17, 2024
Morgan StanleyMeta Marshall$38$38.02 -76.7%Jun 13, 2024
UBSJoshua Spector$38$35.55 -76.7%May 30, 2024
Mizuho SecuritiesJohn Roberts$36$33.44 -77.9%May 7, 2024
SusquehannaAnalyst unavailable$40$35.68 -75.5%Feb 2, 2023
SusquehannaMehdi Hosseini$50$42.12 -69.4%Jan 30, 2022
BarclaysTim Long$52$40.56 -68.1%Jan 27, 2022
OppenheimerMartin Yang$48$34.93 -70.6%Oct 27, 2021
Show less

Track every rating change on GLW the moment it posts. Free to start.

Start free

Company context

Snapshot as of publication

Corning Incorporated operates in optical communications, display, specialty materials, automotive, and life sciences businesses in the United States, Canada, Mexico, Japan, Taiwan, China, South Korea, Germany, and internationally. The company provides optical fibers and cables; and hardware and equipment products, such as cable assemblies, fiber optic hardware and connectors, optical components and couplers, closures, network interface devices, and other accessories for the telecommunications industry, businesses, governments, and individuals. It also offers glass substrates for flat panel displays, including liquid crystal displays and organic light-emitting diodes that are used in televisions, notebook computers, desktop monitors, tablets, and handheld devices.…

Historical context

All GLW earnings

Technology peers this season

Latest reports in the same sector

Latest beats and misses

Who reports next

Get the GLW recap when the next report posts

One email per quarter with the scorecard, the market reaction and what changed on the call. No account needed.

Sources

  1. Earnings call transcript and parsed analysis · 2026-05-11T10:29:34.698584+00:00
  2. FN2 earnings calendar · 2026-07-26T00:37:55.686058+00:00
  3. Polygon adjusted daily market bars · 2026-10-08T10:30:47.004558+00:00
  4. Financial Modeling Prep analyst price-target consensus and quote snapshot · 2026-10-08T10:30:47.001704+00:00

Methodology

Reported and consensus figures come from FN2's earnings event records. Market reaction and volume are calculated from daily adjusted bars around the event; abnormal move subtracts the SPY move over the same window.

Analyst target low, average, and high values are derived at request time from each named analyst's latest persisted FMP target. The current-price marker comes from FN2's persisted market snapshot. They are sell-side estimates, not an FN2 valuation or recommendation.

Transcript intelligence is a structured synthesis of the current and prior earnings-call analyses. Missing values stay missing and are never estimated.

By FN2 Research · Updated · As of 2026-10-08. For educational purposes only; not investment advice.